Phyton Biotech, LLC
1503 Cliveden Avenue
Delta
British Columbia
V3M 6P7
Canada
Tel: 604-777-2340
Website: http://www.phytonbiotech.com/
Email: info@phyton.com
18 articles about Phyton Biotech, LLC
-
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
4/18/2019
Phyton Biotech and AqVida are pleased to announce today that they have received European approval from the EDQM for AqVida’s paclitaxel injectable FDF.
-
Phyton Biotech Partners with PellePharm to Develop Renewable Supply of Cyclopamine for Investigational Topical Cancer Therapy
1/31/2019
Phyton Biotech and PellePharm today announced an exclusive partnership to develop a plant cell culture-based process to enable the future renewable production of the raw material for PellePharm’s patidegib, an investigational topical therapy for Gorlin Syndrome and High Frequency Basal Cell Carcinoma (BCC)
-
Phyton Biotech Partners with Agenus to Revolutionize QS-21 Production
1/3/2019
Phyton Biotech today announced an exclusive partnership with Agenus Inc. to develop an alternative manufacturing process for QS-21 to ensure a sustainable supply of this key vaccine ingredient.
-
Phyton Biotech Unifies International Operations Under New Leadership
1/3/2018
Phyton Biotech announced the promotion of Colin Marr to President of Phyton Ltd., the world’s leader in commercial-scale plant cell fermentation technology and DFB’s wholly-owned subsidiary.
-
Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin
11/29/2017
Bill & Melinda Gates Foundation invests in R&D pilot for anti-malarial active pharmaceutical ingredients.
-
Patent Application Covering A Novel Production Method For Ingenol Mebutate At Phyton Biotech Is Published By World Intellectual Property Organization (WIPO)
9/30/2016
-
Phyton Biotech Achieves Manufacturing Milestone With Thapsigargin, The Active Agent In Mipsagargin
8/22/2016
-
Patent Application For GenSpera Partner Phyton Biotech, Inc. Is Published By World Intellectual Property Organization (WIPO)
7/13/2015
-
Phyton Biotech, Inc. Receives CEP for Docetaxel API
6/10/2013
-
Phyton Biotech, Inc. Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation
7/17/2012
-
Phyton Biotech, Inc. Files Patent Infringement Lawsuit Against Samyang Corp.
10/24/2011
-
Phyton Biotech, Inc. Receives "Research Group of the Year" Award
10/17/2011
-
European Patent Office to Issue Patent to Phyton Biotech, Inc. Covering Methods of Making Taxanes — Compounds Useful in Cancer Treatment
10/13/2009
-
Phyton Biotech, Inc. Acquires Assets of Natural Pharmaceuticals, Inc.
10/12/2009
-
Princeton Phyton Biotech, Inc. Cutting Jobs
1/10/2008
-
Phyton Biotech, Inc. Acquires Novel Glyco-Engineering Technology, Adds Enhanced Capacity to Manufacture Therapeutic Proteins
5/3/2007
-
Phyton Biotech, Inc. Signs Development Agreement With Insmed Incorporated
7/31/2006
-
Phyton Biotech, Inc., A DFB Pharmaceuticals, Inc. Affiliate, Signs Licensing Agreement With DiAthegen, LLC To Commercialize Growth Hormone Receptor Antagonist That Treats Acromegaly, Cancer, Diabetes
4/11/2006